HRP Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal KDM1/LSD1 antibody - conjugated to HRP. Nucleus marker. Suitable for IHC-P, WB and reacts with Human, Rat, Mouse samples. Cited in 1 publication.
View Alternative Names
AOF2, BHC110, KDM1, KIAA0601, LSD1, KDM1A, Lysine-specific histone demethylase 1A, BRAF35-HDAC complex protein BHC110, Flavin-containing amine oxidase domain-containing protein 2, [histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HRP Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker (AB195897)
IHC image of KDM1/LSD1 staining in a section of formalin-fixed paraffin-embedded normal human testis*. The section was pre-treated using pressure cooker heat mediated antigen retrieval with sodium citrate buffer (pH6) for 30mins, and incubated overnight at +4°C with ab195897 at 1/50 dilution. DAB was used as the chromogen (ab103723), diluted 1/100 and incubated for 10min at room temperature. The section was counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- WB
Lab
Western blot - HRP Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker (AB195897)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% milk before being incubated with ab195897 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
All lanes:
Western blot - HRP Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker (ab195897) at 1/5000 dilution
Lane 1:
Western blot - HeLa whole cell lysate (<a href='/en-us/products/cell-lysates/hela-whole-cell-lysate-ab150035'>ab150035</a>) at 10 µg
Lane 2:
Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg
Lane 3:
PC12 (Rat adrenal pheochromocytoma cell line) Whole Cell Lysate at 10 µg
Predicted band size: 92 kDa
Observed band size: 110 kDa
true
Exposure time: 4min
- WB
Lab
Western blot - HRP Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker (AB195897)
ab195897 was shown to specifically react with KDM1 / LSD1 in wild-type HAP1 cells as signal was lost in KDM1A (KDM1 / LSD1) knockout cells. Wild-type and KDM1A (KDM1 / LSD1) knockout samples were subjected to SDS-PAGE. ab195897 and ab184095 (Mouse monoclonal [mAbcam 9484] to GAPDH - Loading Control (Alexa Fluor® 680) loading control) were incubated overnight at 4°C at 1/5000 dilution and 1/20000 dilution respectively. The loading control was imaged using the Licor Odyssey CLx prior to blots being developed with ECL technique.
All lanes:
Western blot - HRP Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker (ab195897) at 1/5000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
KDM1A (KDM1 / LSD1) knockout HAP1 whole cell lysate at 20 µg
Predicted band size: 92 kDa
Observed band size: 110 kDa
false
Exposure time: 20min
Related conjugates and formulations (4)
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker
-
Anti-KDM1/LSD1 antibody [EPR6825] - Nuclear Marker and ChIP Grade
-
Anti-KDM1/LSD1 antibody [EPR6825] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20:1039-45 PubMed26941806
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com